A Study to Assess Effect of Glucocil® on Metabolic Health in Individuals With Prediabetes and Type 2 Diabetes Mellitus.

StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status changed: Unknown → Completed Show 6 more changesShow less
    • Primary completion date changed from estimate of Dec 25, 2024 to Mar 26, 2025
    • Enrollment target: estimated 100 to confirmed 104
    • Study sites: 5 to 6
    • Start date changed from estimate of Jul 25, 2024 to Sep 12, 2024
    • Eligibility criteria expanded, about 27 words
    • Secondary endpoints: details revised at 9 of 9 entries
  2. Changed Registry marked status Unknown; last known: Not Yet Recruiting
  3. Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A randomized, double-blind, placebo-controlled study to assess the effect of Glucocil® on metabolic health in individuals with prediabetes and Type 2 Diabetes Mellitus.
Trial Details
NCT Number NCT06496893
Lead Sponsor Vedic Lifesciences Pvt. Ltd.
Conditions
(from sponsor)		 Pre Diabetes, Type2 Diabetes Mellitus
Related terms Glucose Intolerance
Enrollment 104 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov